A quiet but monumental shift is reshaping the foundations of the pharmaceutical industry, driven by a convergence of unprecedented demand for new therapies and the fragile realities of a globally interconnected supply chain. Eli Lilly and Company is at the forefront of this transformation,
The Dawn of a Biomanufacturing Boom A wave of unprecedented capital is reshaping the American industrial landscape, signaling the start of a biomanufacturing investment super-cycle that promises to redefine domestic production for decades to come. An analysis of recent investment trends reveals a
A New Frontier in National Security: The Dawn of Intelligent Manufacturing The intricate web of global supply chains, once a symbol of efficiency, now represents a critical vulnerability for the United States' defense industrial base. Recent geopolitical shifts have exposed the risks of relying on
The seemingly harmless act of replacing a refrigerator water filter has become a minefield for consumers, with a flood of counterfeit products threatening both health and home appliances. In response, a major American company is betting billions that the best defense is a radical offense: bringing
A single scheduled review of a continental trade pact has rapidly unraveled the typically cordial relationship between the United States and Canada, revealing deep-seated frictions that extend far beyond mere economic policy. The impending talks over the United States–Mexico–Canada Agreement
In a decisive pivot toward domestic supply chain security, Swiss contract development and manufacturing organization Siegfried is making a significant move to solidify its foothold in the United States, announcing a series of acquisitions designed to bolster its small-molecule drug substance
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59